Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
biochemistry, genetics and molecular biology
A Novel Gene, FGA7, Is Fused to RUNX1/AML1 in a t(4;21)(q28;q22) in a Patient with T-Cell Acute Lymphoblastic Leukemia
Genes Chromosomes and Cancer, Volume 39, No. 2, Year 2004
Notification
URL copied to clipboard!
Description
AML1 is among the most frequent targets of chromosomal rearrangements in human leukemias. We report here the molecular analysis of a t(4;21)(q28;q22) that has disrupted AML1 in a patient with de novo T-cell acute lymphoblastic leukemia. By using 3′-RACE analysis, we show that this rearrangement results in the fusion of a novel gene immediately downstream of exon 5 or exon 6 of AML1, indicating that the AML1 breakpoint lies in intron 6 and that alternative fusion splice variants are generated. The sequence of the novel gene, located at 4q28, does not have any significant homology with any of the known genes in the human GenBank DNA database. However, the first 118 bases are identical to a part of a human ovarian EST. Also, its high homology with mouse and rat sequences suggests that this sequence most probably represents a part of a novel gene, which we named FGA7 (Fused Gene 7 to AML1). Following the AML1 open reading frame, the FGA7 sequence encodes an unknown protein of 27 amino acids. We isolated three bacterial artificial chromosome (BAC) clones that contain the FGA7 sequence and confirmed the breakpoint of the gene on the patient's metaphase spreads by fluorescence in situ hybridization using these BACs as probes. RT-PCR and Northern blot analyses revealed that FGA7 is expressed in ovarian and skeletal muscle tissues. The predicted AML1-FGA7 chimeric proteins contained a limited number of residues fused to AML1 in a situation similar to that reported for the AML1-EAP fusion that is a product of t(3;21). It is possible that the expression of a constitutively shortened AML1 could compete with full-length AML1 and act as a dominant negative inhibitor of the promoters that the core binding factor activates. © 2003 Wiley-Liss, Inc.
Authors & Co-Authors
Mikhail, Fady M.
Egypt, Alexandria
Faculty of Medicine
United States, Chicago
University of Illinois at Chicago
Coignet, Lionel
United States, Buffalo
Roswell Park Cancer Institute
Hatem, Nadia L.
Egypt, Alexandria
Faculty of Medicine
Mourad, Zeinab Ibrahim
Egypt, Alexandria
Faculty of Medicine
Farawela, Hala M.
Egypt, Cairo
Faculty of Medicine
Elkaffash, Dalal
Egypt, Alexandria
Faculty of Medicine
Farahat, Nahla Mohamed Gamal
Egypt, Alexandria
Faculty of Medicine
Nucifora, Giuseppina
United States, Chicago
University of Illinois at Chicago
Statistics
Citations: 34
Authors: 8
Affiliations: 4
Identifiers
Doi:
10.1002/gcc.10302
ISSN:
10452257
Research Areas
Genetics And Genomics
Health System And Policy